News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
331 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (331)
2 (134)
3 (3)
4 (4)
5 (239)
6 (297)
7 (254)
8 (229)
9 (142)
10 (7)
11 (9)
12 (228)
13 (282)
14 (268)
15 (254)
16 (160)
17 (2)
18 (5)
19 (218)
20 (259)
21 (132)
22 (18)
23 (29)
24 (4)
25 (14)
26 (221)
27 (273)
28 (265)
29 (229)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Bruker Reports Third Quarter 2018 Financial Results
Bruker Corporation today announced financial results for its third quarter and nine months ended September 30, 2018.
November 1, 2018
·
19 min read
Biotech Beach
Inogen Announces Participation in the 2018 Stifel Healthcare Conference
Inogen, Inc. today announced that the Company’s management will be participating in the 2018 Stifel Healthcare Conference in New York City.
November 1, 2018
·
1 min read
Biotech Bay
Arcus Biosciences Announces Participation at Three Investor Conferences in November 2018
Arcus Biosciences, Inc. today announced that members of the management team will participate at the following upcoming investor conferences:
November 1, 2018
·
1 min read
BioMidwest
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
edpace Holdings, Inc. today announced that it will present at the following investor conference in November:
November 1, 2018
·
1 min read
Business
Quanterix Corporation Releases Operating Results for Third Quarter 2018
85% revenue growth
November 1, 2018
·
7 min read
Business
Insulet Reports Third Quarter 2018 Revenue of $151.1 Million, Up 24% Year-Over-Year, and Gross Margin Over 67%, Up 700 Basis Points
Achieved Both Positive Operating and Net Income for the First Time in Insulet’s History
November 1, 2018
·
10 min read
Business
Revance Releases Third Quarter 2018 Results
Chief Financial Officer Toby Schilke and Interim Head of Commercial - Aesthetics & Therapeutics Dustin Sjuts to assume roles on November 5
November 1, 2018
·
13 min read
Genetown
Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting
Presentations to feature key opinion leaders and expand on preclinical data from Synlogic’s first immuno-oncology candidate, accepted for presentation at SITC 2018
November 1, 2018
·
4 min read
Business
Tandem Diabetes Care Reports Third Quarter 2018 Financial Results
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2018.
November 1, 2018
·
8 min read
Business
Puma Biotechnology Reports Third Quarter 2018 Financial Results
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2018
November 1, 2018
·
15 min read
Previous
13 of 34
Next